Ono Pharmaceutical (OPHLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2020 | 06-2020 | 12-2019 | 06-2019 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 787,720 | 603,114 | 617,467 | 360,542 | 706,743 |
| Marketable Securities | 77,888 | 305,477 | 289,423 | 104,787 | 148,941 |
| Receivables | 757,997 | 719,736 | 755,467 | 746,145 | 709,137 |
| Inventories | 349,069 | 321,501 | 294,142 | 285,258 | 290,898 |
| Other current assets | 158,982 | 139,286 | 117,465 | 124,069 | 103,050 |
| TOTAL | $2,131,657 | $2,089,115 | $2,073,965 | $1,620,801 | $1,958,769 |
| Non-Current Assets | |||||
| PPE Net | 1,069,842 | 1,050,593 | 1,056,031 | 1,045,790 | 922,149 |
| Investments And Advances | 2,532,764 | 2,260,133 | 2,109,946 | 2,347,491 | 2,341,269 |
| Intangibles | 613,679 | 607,216 | 622,757 | 579,788 | 498,627 |
| Other Non-Current Assets | 295,932 | 303,068 | 202,107 | 239,785 | 40,923 |
| TOTAL | $4,512,217 | $4,221,010 | $3,990,841 | $4,212,854 | $3,802,968 |
| Total Assets | $6,643,873 | $6,310,134 | $6,064,796 | $5,833,646 | $5,761,737 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 3,438 |
| Accounts payable and accrued liabilities | 298,046 | 271,216 | 275,144 | 274,656 | 265,635 |
| Other current liabilities | 312,653 | 352,647 | 311,199 | 320,839 | 230,607 |
| TOTAL | $766,636 | $708,948 | $666,558 | $658,831 | $578,529 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 4,230 |
| Other Non-Current Liabilities | 127,699 | 114,018 | 116,638 | 117,072 | 39,537 |
| TOTAL | $137,616 | $124,081 | $126,426 | $126,991 | $52,848 |
| Total Liabilities | $904,252 | $833,029 | $792,994 | $785,840 | $631,377 |
| Shareholders' Equity | |||||
| Common Shares | 163,165 | 161,429 | 159,694 | 157,958 | 156,222 |
| Retained earnings | 5,212,337 | 4,976,932 | 4,701,338 | 4,587,747 | 4,347,495 |
| Other shareholders' equity | 622,354 | 594,802 | 664,328 | 583,500 | 814,951 |
| TOTAL | $5,739,621 | $5,477,105 | $5,271,802 | $5,047,807 | $5,130,360 |
| Total Liabilities And Equity | $6,643,873 | $6,310,134 | $6,064,796 | $5,833,647 | $5,761,737 |